AU6916100A - Helical cytokine zalpha48 - Google Patents

Helical cytokine zalpha48

Info

Publication number
AU6916100A
AU6916100A AU69161/00A AU6916100A AU6916100A AU 6916100 A AU6916100 A AU 6916100A AU 69161/00 A AU69161/00 A AU 69161/00A AU 6916100 A AU6916100 A AU 6916100A AU 6916100 A AU6916100 A AU 6916100A
Authority
AU
Australia
Prior art keywords
zalpha48
helical cytokine
cytokine
helical
cytokine zalpha48
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU69161/00A
Other languages
English (en)
Inventor
Darrell C. Conklin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of AU6916100A publication Critical patent/AU6916100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU69161/00A 1999-08-18 2000-08-18 Helical cytokine zalpha48 Abandoned AU6916100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37682699A 1999-08-18 1999-08-18
US09376826 1999-08-18
PCT/US2000/022714 WO2001012665A2 (fr) 1999-08-18 2000-08-18 Cytokine zalpha48 a enroulement en helice

Publications (1)

Publication Number Publication Date
AU6916100A true AU6916100A (en) 2001-03-13

Family

ID=23486680

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69161/00A Abandoned AU6916100A (en) 1999-08-18 2000-08-18 Helical cytokine zalpha48

Country Status (5)

Country Link
EP (1) EP1204681A2 (fr)
JP (1) JP2003508032A (fr)
AU (1) AU6916100A (fr)
CA (1) CA2381794A1 (fr)
WO (1) WO2001012665A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020168756A1 (en) 2001-03-23 2002-11-14 Fuji Photo Film Co., Ltd. Particle size variable reactor
US7077982B2 (en) 2001-03-23 2006-07-18 Fuji Photo Film Co., Ltd. Molecular electric wire, molecular electric wire circuit using the same and process for producing the molecular electric wire circuit
JP4294946B2 (ja) 2002-12-13 2009-07-15 富士フイルム株式会社 標的検出装置及び標的検出方法並びに標的検出用基材
US7076127B2 (en) 2003-01-14 2006-07-11 Fuji Photo Film Co., Ltd. Optical switch and safety apparatus using the same
CA2546796A1 (fr) * 2003-11-26 2005-06-16 Zymogenetics, Inc. Hormones peptidiques zalpha48 et zsig97

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999063088A2 (fr) * 1998-06-02 1999-12-09 Genentech, Inc. Proteines membranaires et acides nucleiques codant ces proteines

Also Published As

Publication number Publication date
CA2381794A1 (fr) 2001-02-22
EP1204681A2 (fr) 2002-05-15
JP2003508032A (ja) 2003-03-04
WO2001012665A3 (fr) 2001-07-12
WO2001012665A2 (fr) 2001-02-22

Similar Documents

Publication Publication Date Title
AU4943200A (en) Modified cytokine
AU4368100A (en) Proning bed
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU2965600A (en) Interleukin-20
AU5967600A (en) Candystraw
AU6335000A (en) Depthimeter
AU4115400A (en) Short-circuiter
AU7514700A (en) Cyanopiperidines
AU5691800A (en) Structure
AU2023701A (en) Sketcher
AU2804600A (en) Arylaminoalkylamides
AU6440900A (en) Homogentisate-dioxygenase
AU2699800A (en) Organoceramics
AU2201501A (en) Structure
AU6098300A (en) Follistatin-3
AU4916900A (en) Benzofuranylsulfonates
AU6916100A (en) Helical cytokine zalpha48
AU4561600A (en) Benzofuranylaminoalcohols
AU1901801A (en) Glucofuranoses
AU5489900A (en) Helical cytokine zalpha33
AU4435300A (en) Hula-hoop
AU2582200A (en) Windturbine
AU7513400A (en) Hydantoin-racemase
AU1915601A (en) Periotome

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase